{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:24:18Z","timestamp":1787772258044,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) is an escalating global health issue. Early detection and precise diagnosis are imperative for effective management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To evaluate the sociodemographic and clinical attributes of study participants concerning their ultrasound grading with FibroScan and FLI values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>A cross-sectional study was carried out among patients visiting gastroenterology clinics at a tertiary care hospital situated in Karachi, Pakistan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Material:<\/jats:title>\n                    <jats:p>We included participants after written informed consent underwent an extensive array of laboratory assessments, encompassing liver function tests, lipid profile, fasting blood sugar analysis, hepatitis B and C screening, and abdominal ultrasound, while those with positive hepatitis B or C markers, documented alcohol use, or those who declined to offer informed consent were excluded from the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis:<\/jats:title>\n                    <jats:p>Data were analyzed using SPSS version 26.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Around 225 patients were studied with a median age of 42 years (IQR = 34\u201350 years). Metabolic syndrome (MetS) was present in 61.8%. Steatosis was not found among 4.9% of patients, whereas severe steatosis was seen among 51.1% of patients. Significant variations in BMI, WC, GGT, and TG levels were identified when comparing FLI scores. The same was observed for the frequency of MetS as FLI scores increased. The agreement between FLI and ultrasound observations was found to be slight (k = 0.077,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.027). On the multivariable regression model, having diabetes, elevated serum glutamate pyruvate transaminase levels and mild disease on ultrasound were associated with increased odds of severe steatosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>FLI is a good predictor of frequency of MetS and NAFLD and correlates well with increasing steatosis score (CAP) on FibroScan which can be utilized for early detection of NAFLD in primary care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1789_23","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T08:03:46Z","timestamp":1713773026000},"page":"1488-1495","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease"],"prefix":"10.4103","volume":"13","author":[{"given":"Marium","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabeeya","family":"Saeed","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Kamani","sequence":"additional","affiliation":[{"name":"Gastroenterology, Liaquat National Hospital and Medical College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noureen","family":"Durrani","sequence":"additional","affiliation":[{"name":"Publication Department, Liaquat National Hospital and Medical College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Student, Liaquat National Hospital and Medical College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCG.0000000000000116","article-title":"World Gastroenterology Organisation global guidelines:Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"48","author":"LaBrecque","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"e940691","DOI":"10.12659\/MSM.940691","article-title":"Association between fatty liver index, controlled attenuation parameter, and metabolic syndrome stages:A community-based study","volume":"29","author":"Chong","year":"2023","journal-title":"Med Sci Monit"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease-A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease:Expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region:A Lancet Gastroenterology and Hepatology Commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5005\/jp-journals-10018-1189","article-title":"Nonalcoholic fatty liver disease in South Asia","volume":"6","author":"Pati","year":"2016","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"15532","DOI":"10.3748\/wjg.v20.i42.15532","article-title":"Liver transplantation and non-alcoholic fatty liver disease","volume":"20","author":"Zezos","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.dld.2020.10.014","article-title":"Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population","volume":"53","author":"Schonmann","year":"2021","journal-title":"Dig Liver Dis"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.3748\/wjg.v22.i10.3023","article-title":"Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease","volume":"22","author":"Motamed","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"155222","DOI":"10.1016\/j.metabol.2022.155222","article-title":"Association of fatty liver index with all-cause and disease-specific mortality:A nationwide cohort study","volume":"133","author":"Chung","year":"2022","journal-title":"Metabolism"},{"key":"R12-20240828","first-page":"53","article-title":"Frequency of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus and its relationship with glycemic status","volume":"20","author":"Hossain","year":"2021","journal-title":"IOSR J Dent Med Sci"},{"key":"R13-20240828","first-page":"e16029","article-title":"Perception of non-alcoholic fatty liver disease:Real-life experience from Pakistan","volume":"13","author":"Butt","year":"2021","journal-title":"Cureus"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/liv.13558","article-title":"Clinical implications of controlled attenuation parameter in a health check-up cohort","volume":"38","author":"Kwak","year":"2018","journal-title":"Liver Int"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41598-018-20166-x","article-title":"A systematic machine learning based approach for the diagnosis of non-alcoholic fatty liver disease risk and progression","volume":"8","author":"Perveen","year":"2018","journal-title":"Sci Rep"},{"key":"R17-20240828","first-page":"121","article-title":"Identification of metabolic risk phenotypes predisposing to non-alcoholic fatty liver disease in a Pakistani Cohort","volume":"33","author":"Ghani","year":"2017","journal-title":"Pak J Med Sci"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/DMSO.S189544","article-title":"The fatty liver index, a simple and useful predictor of metabolic syndrome:Analysis of the Korea National Health and Nutrition Examination Survey 2010-2011","volume":"12","author":"Khang","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R19-20240828","first-page":"e16414","article-title":"Estimation of liver fat by FibroScan in patients with nonalcoholic fatty liver disease","volume":"13","author":"Shrestha","year":"2021","journal-title":"Cureus"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","article-title":"Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease","volume":"65","author":"Boursier","year":"2016","journal-title":"J Hepatol"},{"key":"R21-20240828","first-page":"1","article-title":"Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan:A call for action","volume":"5","author":"Kamani","year":"2024","journal-title":"Hepatol Forum"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1789_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:34:24Z","timestamp":1787769264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1789_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1789_23","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"2023-11-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}